Loading clinical trials...

Infrared Thermal Imaging in Evaluating the Percutaneous Transluminal Angioplasty for Peripheral Artery Disease | Clinical Trials | Clareo Health

UNKNOWN

Infrared Thermal Imaging in Evaluating the Percutaneous Transluminal Angioplasty for Peripheral Artery Disease

NCT05941533•Fangge Deng

View on ClinicalTrials.gov

Summary

Determination of IRTI (infrared thermal imaging) can be used to evaluate PAD patients with critical limb ischemia with different degrees of lesion. IRTI can be used to evaluate the foot blood perfusion after percutaneous transluminal angioplasty (PTA) treatment and determine the success rate of surgery. IRTI can be used as an effective follow-up tool for patients after surgery.

Eligibility

Age

18 - 80 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Patients with Rutherford grade 3, 4, 5, or 6.
•Patients with indications for lower extremity arterial PTA: severe intermittent claudication, rest pain, ulceration or gangrene.
•Patients who required PTA of only one limb (left versus right).

Exclusion Criteria

•Patients with body temperature above 37 ° C.
•Patients with indications for open surgery.
•Patients requiring major amputation (above the ankle).
•Patients with acute occlusive or embolic limb ischemia.
•Patients with deep venous thrombosis of the lower extremity.

Locations (1)

Fangge Deng

Guangzhou, Guangdong, China

Key Dates

Start Date

March 1, 2023

Primary Completion Date

March 1, 2024

Completion Date

June 1, 2024

Last Updated

July 18, 2023

Enrollment

ESTIMATED participants

Conditions

Peripheral Artery Disease (PAD)

Safety and Effectiveness of the Peripheral Balloon-Expandable Covered Stent System for Iliac Artery Stenosis/Occlusion. (SELECT)

NCT06605209

Peripheral Artery Disease (PAD)

View study

RECRUITING

Angioplasty With Shockwave IVL Catheter System in Femoropopliteal Lesions

NCT06713850

Peripheral Artery Disease (PAD)Chronic Limb Threatening Ischemia

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 18, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Infrared Thermal Imaging in Evaluating the Percutaneous Transluminal Angioplasty for Peripheral Artery Disease

Inclusion Criteria

Exclusion Criteria

Safety and Effectiveness of the Peripheral Balloon-Expandable Covered Stent System for Iliac Artery Stenosis/Occlusion. (SELECT)

Angioplasty With Shockwave IVL Catheter System in Femoropopliteal Lesions

Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease

Hemodynamic Parameters in People With Atherosclerotic Vascular Disease Referred to a Secondary Prevention and Cardiovascular Rehabilitation Program

Effect of Diabetic Foot Exercises on Peripheral Vascular Status in Type 2 Diabetes Mellitus Patients

Vascular Physician Offer and Report (VAPOR) Trial